WallStreetZenWallStreetZen

How to Buy Kintara Therapeutics Stock

Kintara Therapeutics Inc

Kintara Therapeutics, Inc. , a clinical stage drug development company, focuses on developing and commercializing anti-cancer therapies to treat cancer patients.

Kintara Therapeutics stock last closed at $3.68, up 2.79% from the previous day, and has decreased 81.27% in one year. It has underperformed other stocks in the Biotechnology industry by 0.54 percentage points. Kintara Therapeutics stock is currently +31.43% from its 52-week low of $2.80, and -91.24% from its 52-week high of $42.00.

As of Mar 24, 2023, there are 1.68M KTRA shares outstanding. The market cap of KTRA is $6.17M. In the last 24 hours, 2168 KTRA shares were traded.

How to Buy Kintara Therapeutics Stock

Not sure how to invest in Kintara Therapeutics stock? Here's how.
  1. Choose where to buy Kintara Therapeutics stock: You need to choose a stock brokerage, but don't worry - we've analyzed dozens of online stock brokerages and apps to help you decide where to buy Kintara Therapeutics stock.
  2. Open your brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've found.
  3. Fund your brokerage account: Select your payment method and add your information.
  4. Evaluate Kintara Therapeutics stock: The Kintara Therapeutics ticker symbol is KTRA. Is Kintara Therapeutics stock a good investment? Should you buy shares of KTRA? How do KTRA's underlying business fundamentals look? Do top analysts think Kintara Therapeutics is a good buy? Why has KTRA's stock price moved recently? (Hint: Our stock research tools can help you understand if KTRA is a good stock to buy).
  5. Execute your KTRA purchase: Decide if you will purchase KTRA shares at the current market price or use a limit order to buy KTRA stock at a particular price.
  6. Get the latest scoop on your KTRA investment: Create a watchlist to key updates about your investment in Kintara Therapeutics stock.

Step 1: Choose where to buy Kintara Therapeutics stock

You need a brokerage account in order to access the NASDAQ market and buy KTRA shares.

A brokerage account enables you to buy and sell a number of financial instruments, such as stocks, bonds, mutual funds, and ETFs.

Our preferred brokerage: eToro

In our opinion, eToro is the best brokerage. eToro gives you:

  • Invest in stocks with 0% commissions: Invest without commissions.
  • Buy fractional shares: Even if you don't have the money to buy a full share, you can still purchase the stock.
  • Access to world financial markets: From Technology to Real Estate, New York to Tokyo — you can fill your portfolio with stocks from the globe's leading exchanges.
  • Social investing: eToro boasts a community with more than 20 million users around the world. Talk to, learn from, and copy the crypto trades of top investors.
  • Security: eToro is a regulated and licensed brokerage platform.
  • Buy other financial assets: Such as ETFs and cryptos.

Get $10 towards your stock purchase by creating an account with eToro today.

Open eToro Account

Step 2: Open your brokerage account

Now that you've chosen your brokerage, it's time to fill out some personal details so you are able to buy KTRA stock today.

How to Create a New Account on eToro

  1. Click here to get started.
  2. Provide your personal details to start your new trading account.
  1. Send your info by clicking the "Create Account" button.
Get started with eToro today

Step 3: Fund your brokerage account

Now that you've created your account on stock market app, you need to deposit funds:

Check out the walkthrough below for more details transferring money into your new investment account.

Get started with eToro today

Step 4: Evaluate Kintara Therapeutics stock

Once you have selected the best place to buy Kintara Therapeutics stock, it's important to analyze their stock before you invest, so you truly understand the risk as well as the opportunity.

Kintara Therapeutics stock data

KTRA Price
$3.68
1w %
-4.42%
1y %
-81.27%
5y %
-99.25%
P/E
-0.25x
P/B
0.93x
P/S
N/A
PEG
N/A
Revenue
$0.00
Earnings
-$19.22M
Fore. Rev. Growth
N/A
Fore. Earn. Growth
N/A
Market Cap
$6.17M
Next Earnings
May 11, 2023
Next Dividend
N/A

Kintara Therapeutics Zen Score

WallStreetZen was built to help part-time investors perform more accurate fundamental analysis.

You can see all of the due diligence checks on KTRA's stock page.

Is KTRA stock undervalued or overvalued?

You can use a variety of different financial metrics, analyses, models, and charts to gauge KTRA's intrinsic value.

Using relative valuations methods:

  • KTRA may be undervalued based on its P/B ratio of 0.93x, relative to Biotechnology industry P/B ratio of 4.89x

You can do more valuation analysis on KTRA's stock here.

KTRA Financial Health Summary

Passed Financial Due Diligence Checks:

  • There are more short-term assets than long-term liabilities on the KTRA balance sheet.
  • There are more short-term assets than short-term liabilities on the KTRA balance sheet.

Failed Financial Due Diligence Checks:

  • KTRA has $4.87M in cash and short term investments. This is not enough to cover its annual cash burn of $18.98M.
  • KTRA has a relatively high debt to equity ratio of 0.5.
  • KTRA has cash burn of 18977000. It does not have enough cash and short-term investments to cover this.
  • Total KTRA debt is higher than 5 years ago, relative to shareholder equity.

Do Wall Street analysts think it's a good time to buy KTRA stock

Out of 1 Wall Street analysts who track KTRA, the consensus analyst rating on KTRA is a Hold

Please note that analyst forecasts are not recommendations, nor are they financial advice.

Most Recent KTRA Analyst Ratings

Jason McCarthy, a bottom 2% analyst from Maxim Group downgrades KTRA to a hold rating, on Sep 29, 2022.

You can dive deeper into what analysts are saying on the Kintara Therapeutics stock forecast page.

KTRA Momentum

SMA10
3.6
SMA20
3.96
SMA50
5.35
SMA100
6.18
SMA200
7.52
MACD
-0.53
MACD Signal
-0.63
MACD Histogram
0.1
RSI
41.42
Stochastic %K
40.44
Stochastic %D
41.72
StochRSI %K
79.11
StochRSI %D
80.53

What are KTRA executives and large shareholders up to?

Over the past year, insiders at KTRA have not bought or sold any shares.

Dig into more about who owns KTRA shares here.

Can I get consistent income from KTRA stock?

No, Kintara Therapeutics doesn't provide an income stream by paying out dividends.

KTRA Social Trading Data

One of the reasons eToro is our favorite brokerage is because of its social trading community.

Click below to see what other community members have to say.

Step 5: Execute your KTRA purchase

You have two primary types of orders:

  • Market order: A market order is an order to buy or sell a security at the best price on the market.
    Market orders are usually the best for newer investors.
  • Limit order: A limit order lets you buy or sell a stock at a specific price (or better).
    If you want to be sure you're buying or selling at an exact dollar amount, use a limit order.

Press the Open Trade button and eToro will execute the order.

If you need more help investing in stocks on eToro, watch the how to video below:

Open eToro Account

Step 6: Get the latest scoop on your KTRA investment

Now that you own some KTRA shares, you'll want to stay up-to-date on your new stock purchase.

Make a watchlist to get the latest updates about your KTRA stock.

KTRA Feed

How to Buy Stock in Kintara Therapeutics

To reiterate, here are the 6 steps to buy Kintara Therapeutics stock:

  1. Choose where to buy Kintara Therapeutics stock
  2. Open your brokerage account
  3. Fund your brokerage account
  4. Evaluate Kintara Therapeutics stock
  5. Execute your KTRA purchase
  6. Get the latest scoop on your KTRA investment

If you are looking for a brokerage account, eToro is our favorite venue.

Get Started with eToro Today

If you would like to watch your new investment in Kintara Therapeutics, click below.

NASDAQ: KTRA
$3.68+0.10 (+2.79%)
Updated Mar 24, 2023
Open eToro Account
NASDAQ: KTRA
$3.68+0.10 (+2.79%)
Updated Mar 24, 2023
Open eToro Account

FAQ

How much does it cost to buy one Kintara Therapeutics share?

As of Mar 24, 2023, it costs $3.68 to buy one share of Kintara Therapeutics stock.

Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $1, you can buy 0.272 shares of KTRA.

Get Started with eToro Today

Is now a good time to buy Kintara Therapeutics stock?

According to 1 Wall Street analysts who monitor Kintara Therapeutics, their consensus recommendation is to hold Kintara Therapeutics stock.

What is the best way to buy Kintara Therapeutics stock?

One way to place an order for Kintara Therapeutics stock is with a brokerage account.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.